Physician profile
Michael E Hoffman
NPI 1164697611
$2,334.98
in general payments reported to CMS, 2019-2025
22 companies · $537 in 2025
The $537 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $224 · 2021: $184 · 2022: $171 · 2023: $488 · 2024: $271 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,128.02 |
| Education | $167.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $497.55 | 2019-2023 | |
| Boston Scientific Corporation | $316.41 | 2019-2025 | General - Female Sui |
| Antares Pharma, INC. | $285.60 | 2021-2025 | Xyosted |
| Procept Biorobotics Corporation | $156.31 | 2023 | Aquabeam Robotic System |
| Abc Home Medical Supply, INC. | $156.17 | 2024-2025 | |
| Hollister Incorporated | $147.14 | 2020-2024 | Onli, Infyna Chic, Vapro Pocket |
| Endo Pharmaceuticals INC. | $125.45 | 2020-2023 | Aveed, Edex, Xiaflex |
| Janssen Pharmaceuticals, INC | $119.42 | 2022 | |
| Coloplast Corp | $63.72 | 2023-2025 | Speedicath |
| Abbvie INC. | $56.73 | 2024-2025 | |
| Pfizer INC. | $55.25 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $51.88 | 2024-2025 | Prolaris |
| Cook Medical LLC | $46.80 | 2019-2024 | Litho 150, Cook |
| Janssen Biotech, INC. | $43.96 | 2025 | Tremfya |
| Exact Sciences Corporation | $39.45 | 2023-2024 | Cologuard Collection Kit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $32.77 | 2023 | |
| Rochester Medical Corporation | $31.56 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $31.47 | 2025 | Adstiladrin |
| Teleflex LLC | $20.66 | 2025 | Barrigel |
| Neotract INC. | $19.25 | 2020 | |
| Endo USA, INC. | $19.09 | 2025 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $18.34 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.